Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.

Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.

Item
http://www.wikidata.org/entity/Q40756497
Macrophage plasticity and polarization: in vivo veritasOvarian cancer immunotherapy: opportunities, progresses and challengesMetabolic reprograming in macrophage polarization.Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin.A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer.Monocyte and interferon based therapy for the treatment of ovarian cancer.Antigenic modulation of metastatic breast and ovary carcinoma cells by intracavitary injection of IFN-alpha.Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients.Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial.Metabolic Factors that Contribute to Lupus PathogenesisMultiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study.The Unique Molecular and Cellular Microenvironment of Ovarian CancerMacrophages Reprogrammed In Vitro Towards the M1 Phenotype and Activated with LPS Extend Lifespan of Mice with Ehrlich Ascites CarcinomaA Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron (Peginterferon alfa-2b) and Actimmune (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer
P2860

Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.

Item
http://www.wikidata.org/entity/Q40756497
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Intraperitoneal recombinant ga ...... gen expression on tumor cells.
@en
type
label
Intraperitoneal recombinant ga ...... gen expression on tumor cells.
@en
prefLabel
Intraperitoneal recombinant ga ...... gen expression on tumor cells.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P1433
P1476
Intraperitoneal recombinant ga ...... gen expression on tumor cells.
@en
P2093
P304
P31
P407
P433
P478
P577
P698